InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Cartesian Therapeutics, Inc.

RNAC Clue Score28
United States Fiscal year ends December CIK 0001453687 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

244
Insider
Date
Role
Action
Shares
Price
Amount
Blaine Davis
6 Jan 2026
Chief Financial Officer
Sell
10,591
$6.82
$72.23K
Milos Miljkovic
6 Jan 2026
Chief Medical Officer
Sell
3,573
$6.82
$24.37K
Carsten Brunn
6 Jan 2026
President and CEO
Sell
23,766
$6.82
$162.08K
Emily English
30 Dec 2025
Chief Operations Officer
Exercised, kept
7,500
$3.30
$24.75K
Timothy C Barabe
4 Dec 2025
Director
Buy
30,000
$6.86
$205.80K
Emily English
28 Nov 2025
Chief Operations Officer
Exercised, kept
7,500
$3.30
$24.75K
Emily English
12 May 2025
Chief Operations Officer
Exercised, kept
7,500
$3.30
$24.75K
Emily English
15 Apr 2025
Chief Operations Officer
Exercised, kept
7,500
$3.30
$24.75K
Timothy A Springer
11 Apr 2025
Director
Buy indirect
36,338
$10.77
$391.45K
Timothy A Springer
11 Apr 2025
Director
Buy
6,412
$10.77
$69.07K
Timothy A Springer
10 Apr 2025
Director
Buy indirect
3,451
$10.92
$37.70K
Timothy A Springer
10 Apr 2025
Director
Buy indirect
45,144
$10.43
$471.06K
Timothy A Springer
10 Apr 2025
Director
Buy
609
$10.92
$6.65K
Timothy A Springer
10 Apr 2025
Director
Buy
7,966
$10.43
$83.12K
Timothy A Springer
9 Apr 2025
Director
Buy indirect
178
$9.95
$1.77K
Timothy A Springer
9 Apr 2025
Director
Buy indirect
41,604
$9.43
$392.18K
Timothy A Springer
9 Apr 2025
Director
Buy
31
$9.95
$308.48
Timothy A Springer
9 Apr 2025
Director
Buy
7,342
$9.43
$69.21K
Timothy A Springer
20 Mar 2025
Director
Buy
54,889
$15.59
$855.59K
Timothy A Springer
19 Mar 2025
Director
Buy
20,234
$14.97
$302.96K
Timothy A Springer
18 Mar 2025
Director
Buy
14,740
$14.42
$212.60K
Timothy A Springer
14 Jan 2025
Director
Buy
4,022
$18.00
$72.40K
Timothy A Springer
13 Jan 2025
Director
Buy
8,983
$17.78
$159.74K
Timothy A Springer
13 Jan 2025
Director
Buy
7,962
$16.86
$134.22K
Christopher M Jewell
10 Jan 2025
Chief Scientific Officer
Exercised, kept
9,000
$3.23
$29.07K
Blaine Davis
6 Jan 2025
Chief Financial Officer
Sell
4,028
$16.83
$67.80K
Carsten Brunn
6 Jan 2025
President and CEO
Sell
8,708
$16.83
$146.57K
Emily English
6 Jan 2025
Chief Operations Officer
Sell
906
$16.83
$15.25K
Christopher M Jewell
6 Jan 2025
Chief Scientific Officer
Sell
1,286
$16.83
$21.65K
Milos Miljkovic
6 Jan 2025
Chief Medical Officer
Sell
948
$16.83
$15.96K
Metin Kurtoglu
6 Jan 2025
Chief Technology Officer
Sell
2,458
$16.83
$41.37K
Blaine Davis
3 Jan 2025
Chief Financial Officer
Sell
3,961
$16.72
$66.24K
Carsten Brunn
3 Jan 2025
President and CEO
Sell
8,563
$16.72
$143.19K
Emily English
3 Jan 2025
Chief Operations Officer
Sell
891
$16.72
$14.90K
Christopher M Jewell
3 Jan 2025
Chief Scientific Officer
Sell
1,264
$16.72
$21.14K
Milos Miljkovic
3 Jan 2025
Chief Medical Officer
Sell
932
$16.72
$15.58K
Metin Kurtoglu
3 Jan 2025
Chief Technology Officer
Sell
2,417
$16.72
$40.42K
Emily English
26 Dec 2024
SVP, Head of Manufacturing
Exercised, kept
7,650
$3.30
$25.25K
Timothy A Springer
23 Dec 2024
Director
Buy
5,181
$19.00
$98.44K
Timothy A Springer
20 Dec 2024
Director
Buy
21,800
$18.94
$412.97K
Timothy A Springer
19 Dec 2024
Director
Buy
3,376
$18.93
$63.90K
Timothy A Springer
19 Dec 2024
Director
Buy
10,529
$18.35
$193.20K
Timothy A Springer
19 Dec 2024
Director
Buy
11,303
$17.39
$196.51K
Metin Kurtoglu
10 Dec 2024
Chief Technology Officer
Sold after exercise
2,901
$24.35
$70.64K
Metin Kurtoglu
9 Dec 2024
Chief Technology Officer
Sold after exercise
4,539
$25.83
$117.26K
Metin Kurtoglu
9 Dec 2024
Chief Technology Officer
Sold after exercise
6,224
$25.26
$157.24K
Metin Kurtoglu
21 Nov 2024
Chief Technology Officer
Sold after exercise
32,789
$16.67
$546.56K
Christopher M Jewell
20 Nov 2024
Chief Scientific Officer
Exercised, kept
14,000
$3.23
$45.22K
Metin Kurtoglu
20 Nov 2024
Chief Technology Officer
Sold after exercise
100
$18.09
$1.81K
Metin Kurtoglu
20 Nov 2024
Chief Technology Officer
Sold after exercise
5,600
$17.28
$96.76K
Metin Kurtoglu
19 Nov 2024
Chief Technology Officer
Sold after exercise
200
$19.50
$3.90K
Metin Kurtoglu
18 Nov 2024
Chief Technology Officer
Sold after exercise
17,728
$18.58
$329.43K
Metin Kurtoglu
18 Nov 2024
Chief Technology Officer
Sold after exercise
16,672
$18.19
$303.21K
Timothy A Springer
18 Nov 2024
Director
Buy
20,181
$18.42
$371.74K
Timothy A Springer
18 Nov 2024
Director
Buy
38,114
$17.96
$684.45K
Christopher M Jewell
15 Nov 2024
Chief Scientific Officer
Sold after exercise
16,065
$17.06
$274.09K
Milos Miljkovic
15 Nov 2024
Chief Medical Officer
Sold after exercise
20,000
$17.14
$342.89K
Metin Kurtoglu
15 Nov 2024
Chief Technology Officer
Sold after exercise
22,068
$17.20
$379.50K
Timothy A Springer
15 Nov 2024
Director
Buy
277,246
$17.09
$4.74M
Christopher M Jewell
14 Nov 2024
Chief Scientific Officer
Sold after exercise
17,500
$17.02
$297.82K
Christopher M Jewell
14 Nov 2024
Chief Scientific Officer
Sold after exercise
18,550
$16.34
$303.13K
Milos Miljkovic
14 Nov 2024
Chief Medical Officer
Sold after exercise
35,000
$16.13
$564.64K
Metin Kurtoglu
14 Nov 2024
Chief Technology Officer
Sold after exercise
4,000
$17.06
$68.26K
Metin Kurtoglu
14 Nov 2024
Chief Technology Officer
Sold after exercise
21,900
$16.33
$357.64K
Timothy A Springer
14 Nov 2024
Director
Buy
22,242
$16.97
$377.44K
Timothy A Springer
14 Nov 2024
Director
Buy
74,157
$16.19
$1.20M
Timothy A Springer
4 Oct 2024
Director
Buy
4,879
$23.93
$116.77K
Timothy A Springer
4 Oct 2024
Director
Buy
16,650
$23.57
$392.37K
Timothy A Springer
4 Oct 2024
Director
Buy
48,880
$22.35
$1.09M
Timothy A Springer
4 Oct 2024
Director
Buy
9,892
$21.35
$211.20K
Timothy A Springer
3 Oct 2024
Director
Buy
8,043
$21.86
$175.84K
Timothy A Springer
3 Oct 2024
Director
Buy
21,278
$21.17
$450.56K
Timothy A Springer
3 Oct 2024
Director
Buy
50,489
$20.18
$1.02M
Timothy A Springer
3 Oct 2024
Director
Buy
10,249
$19.01
$194.86K
Timothy A Springer
3 Oct 2024
Director
Buy
29,847
$18.25
$544.58K
Timothy A Springer
2 Oct 2024
Director
Buy
5,514
$17.38
$95.82K
Timothy C Barabe
12 Aug 2024
Director
Buy
7,500
$12.70
$95.25K
Timothy A Springer
12 Aug 2024
Director
Buy indirect
8,016
$12.72
$101.97K
Timothy A Springer
26 Mar 2024
Director
Exercised, kept indirect
1,970,443
$1.46
$2.88M
Timothy A Springer
18 Mar 2024
Director
Buy indirect
19,044
$0.60
$11.40K
Timothy A Springer
18 Mar 2024
Director
Buy indirect
800
$0.61
$488.00
Timothy A Springer
15 Mar 2024
Director
Buy indirect
537,500
$0.59
$314.55K
Timothy A Springer
15 Mar 2024
Director
Buy indirect
1,200
$0.56
$672.00
Timothy A Springer
14 Mar 2024
Director
Buy indirect
648,372
$0.54
$351.68K
Timothy A Springer
14 Mar 2024
Director
Buy indirect
2,000
$0.53
$1.06K
Timothy A Springer
13 Mar 2024
Director
Buy indirect
3,200
$0.58
$1.87K
Timothy A Springer
12 Mar 2024
Director
Buy indirect
1,200
$0.61
$734.64
Timothy A Springer
11 Mar 2024
Director
Buy indirect
1,200
$0.65
$784.92
Timothy A Springer
8 Mar 2024
Director
Buy indirect
4,800
$0.66
$3.19K
Timothy A Springer
7 Feb 2024
Director
Buy indirect
2,400
$0.66
$1.58K
Timothy A Springer
6 Feb 2024
Director
Buy indirect
800
$0.65
$520.00
Timothy A Springer
17 Jan 2024
Director
Buy indirect
800
$0.69
$552.00
Peter G Traber
25 Sep 2023
Chief Medical Officer
Sell
705
$1.06
$747.30
Carsten Brunn
25 Sep 2023
President and CEO
Sell
2,932
$1.06
$3.11K
Peter G Traber
5 Jan 2023
Chief Medical Officer
Sell
20
$1.11
$22.23
Peter G Traber
5 Jan 2023
Chief Medical Officer
Sell
3,445
$1.13
$3.89K
Takashi Kei Kishimoto
5 Jan 2023
Chief Scientific Officer
Sell
20
$1.11
$22.23
Takashi Kei Kishimoto
5 Jan 2023
Chief Scientific Officer
Sell
3,372
$1.13
$3.81K
Lloyd P. Johnston
5 Jan 2023
Chief Operations Officer
Sell
20
$1.11
$22.21
Lloyd P. Johnston
5 Jan 2023
Chief Operations Officer
Sell
3,372
$1.13
$3.81K
Carsten Brunn
5 Jan 2023
President and CEO
Sell
77
$1.12
$85.86
Carsten Brunn
5 Jan 2023
President and CEO
Sell
13,396
$1.13
$15.13K
Peter G Traber
4 Jan 2023
Chief Medical Officer
Sell
15
$1.14
$17.13
Peter G Traber
4 Jan 2023
Chief Medical Officer
Sell
8,164
$1.13
$9.26K
Takashi Kei Kishimoto
4 Jan 2023
Chief Scientific Officer
Sell
11
$1.15
$12.60
Takashi Kei Kishimoto
4 Jan 2023
Chief Scientific Officer
Sell
6,381
$1.13
$7.23K
Lloyd P. Johnston
4 Jan 2023
Chief Operations Officer
Sell
11
$1.14
$12.54
Lloyd P. Johnston
4 Jan 2023
Chief Operations Officer
Sell
6,381
$1.13
$7.23K
Carsten Brunn
4 Jan 2023
President and CEO
Sell
48
$1.15
$54.96
Carsten Brunn
4 Jan 2023
President and CEO
Sell
27,549
$1.13
$31.23K
Carsten Brunn
5 Dec 2022
President and CEO
Sell
4,522
$1.33
$6.01K
Carsten Brunn
28 Sep 2022
President and CEO
Sell
2,692
$1.66
$4.47K
Carsten Brunn
2 Sep 2022
President and CEO
Sell
4,768
$1.85
$8.81K
Carrie Smith Cox
13 Jun 2022
Director
Buy
130,000
$1.15
$149.80K
Timothy C Barabe
9 May 2022
Director
Buy
50,000
$0.77
$38.72K
Timothy A Springer
11 Apr 2022
Director
Buy indirect
6,681,600
—
no price
Carsten Brunn
2 Mar 2022
President and CEO
Sell
5,443
$1.81
$9.86K
Timothy C Barabe
14 Jan 2022
Director
Exercised, kept
10,000
$2.10
$21.00K
Carsten Brunn
5 Jan 2022
President and CEO
Sell
13,597
$3.09
$41.96K
Lloyd P. Johnston
5 Jan 2022
Chief Operations Officer
Sell
3,416
$3.09
$10.54K
Takashi Kei Kishimoto
5 Jan 2022
Chief Scientific Officer
Sell
3,416
$3.09
$10.54K
Peter G Traber
5 Jan 2022
Chief Medical Officer
Sell
3,226
$3.09
$9.96K
Timothy A Springer
15 Dec 2021
Director
Buy indirect
211,190
$2.99
$631.10K
Timothy A Springer
13 Dec 2021
Director
Buy indirect
14,592
$2.98
$43.49K
Timothy A Springer
10 Dec 2021
Director
Buy indirect
58,681
$2.99
$175.44K
Carsten Brunn
10 Dec 2021
President and CEO
Sell
17,196
$2.99
$51.36K
Lloyd P. Johnston
10 Dec 2021
Chief Operations Officer
Sell
4,370
$2.99
$13.05K
Takashi Kei Kishimoto
10 Dec 2021
Chief Scientific Officer
Sell
4,370
$2.99
$13.05K
Peter G Traber
10 Dec 2021
Chief Medical Officer
Sell
4,083
$2.99
$12.20K
Timothy A Springer
9 Dec 2021
Director
Buy indirect
3,748,000
$3.06
$11.47M
Carrie Smith Cox
3 Dec 2021
Director
Buy
17,200
$2.95
$50.66K
Carsten Brunn
2 Dec 2021
President and CEO
Sell
4,746
$2.96
$14.06K
Nishan M DeSilva
2 Dec 2021
Director
Buy
7,000
$2.96
$20.72K
Kevin Tan
2 Dec 2021
Chief Financial Officer
Buy
5,000
$3.03
$15.13K
Carsten Brunn
13 Oct 2021
President and CEO
Sell
15,313
$4.39
$67.22K
Lloyd P. Johnston
13 Oct 2021
Chief Operations Officer
Sell
3,892
$4.39
$17.09K
Takashi Kei Kishimoto
13 Oct 2021
Chief Scientific Officer
Sell
3,892
$4.39
$17.09K
Peter G Traber
13 Oct 2021
Chief Medical Officer
Sell
3,636
$4.39
$15.96K
Carsten Brunn
2 Sep 2021
President and CEO
Sell
4,523
$4.51
$20.40K
Timothy C Barabe
18 Aug 2021
Director
Buy
9,000
$4.00
$36.00K
Carsten Brunn
2 Jun 2021
President and CEO
Sell
4,806
$4.38
$21.04K
Timothy A Springer
26 May 2021
Director
Buy indirect
926,170
$4.00
$3.71M
Peter G Traber
26 May 2021
Chief Medical Officer
Buy
20,000
$3.99
$79.85K
Peter G Traber
25 May 2021
Chief Medical Officer
Buy
5,000
$3.48
$17.40K
Timothy A Springer
25 May 2021
Director
Buy indirect
383,830
$3.55
$1.36M
Peter G Traber
24 May 2021
Chief Medical Officer
Buy
12,500
$3.32
$41.50K
Timothy A Springer
24 May 2021
Director
Buy indirect
590,000
$3.38
$1.99M
Timothy A Springer
21 May 2021
Director
Buy indirect
2,773,479
$3.19
$8.85M
Takashi Kei Kishimoto
7 May 2021
Chief Scientific Officer
Exercised, kept
13,629
$2.77
$37.75K
Timothy C Barabe
26 Mar 2021
Director
Buy
10,000
$4.10
$41.00K
Peter G Traber
18 Mar 2021
Chief Medical Officer
Buy
10,000
$4.50
$45.00K
Lloyd P. Johnston
17 Mar 2021
COO and SVP, R&D
Sell
15,128
$4.45
$67.31K
Peter G Traber
17 Mar 2021
Chief Medical Officer
Buy
10,000
$4.53
$45.30K
Carsten Brunn
2 Mar 2021
President and CEO
Sell
5,461
$4.26
$23.26K
Lloyd P. Johnston
11 Feb 2021
COO and SVP, R&D
Exercised, kept
44,871
$0.63
$28.27K
Peter G Traber
14 Dec 2020
Chief Medical Officer
Buy
40,000
$3.24
$129.42K
Carsten Brunn
2 Dec 2020
President and CEO
Sell
3,323
$3.35
$11.13K
Timothy A Springer
23 Oct 2020
Director
Buy indirect
994,488
$2.71
$2.70M
Takashi Kei Kishimoto
23 Oct 2020
Chief Scientific Officer
Exercised, kept
30,000
$2.77
$83.10K
Timothy A Springer
22 Oct 2020
Director
Buy indirect
1,770,204
$2.63
$4.66M
Timothy A Springer
21 Oct 2020
Director
Buy indirect
880,000
$2.50
$2.20M
Timothy A Springer
20 Oct 2020
Director
Buy indirect
910,000
$2.21
$2.01M
Timothy A Springer
19 Oct 2020
Director
Buy indirect
759,500
$2.36
$1.80M
Timothy A Springer
16 Oct 2020
Director
Buy indirect
218,196
$2.42
$528.03K
Timothy A Springer
9 Oct 2020
Director
Buy indirect
276,703
$2.00
$552.47K
Timothy A Springer
8 Oct 2020
Director
Buy indirect
530,441
$1.89
$1.00M
Timothy A Springer
7 Oct 2020
Director
Buy indirect
654,953
$1.65
$1.08M
Timothy C Barabe
6 Oct 2020
Director
Buy
50,000
$1.68
$83.99K
Timothy A Springer
6 Oct 2020
Director
Buy indirect
2,000,000
$1.68
$3.37M
Carsten Brunn
2 Sep 2020
President and CEO
Sell
3,364
$2.39
$8.03K
Timothy C Barabe
24 Jun 2020
Director
Exercised, kept
32,840
$1.46
$47.95K
Carsten Brunn
2 Jun 2020
President and CEO
Sell
3,253
$3.86
$12.56K
Timothy C Barabe
17 Mar 2020
Director
Buy
5,000
$2.00
$10.00K
Carsten Brunn
3 Mar 2020
President and CEO
Sell
3,374
$3.86
$13.01K
Lloyd P. Johnston
16 Jan 2020
COO and SVP, R&D
Exercised, kept
5,128
$0.47
$2.41K
Carsten Brunn
2 Dec 2019
President and CEO
Sell
14,272
$1.53
$21.81K
Timothy A Springer
14 Aug 2019
Director
Buy indirect
10,000
$1.74
$17.42K
Timothy C Barabe
13 Aug 2019
Director
Buy
10,000
$1.72
$17.20K
Lloyd P. Johnston
23 Jul 2019
COO and SVP, R&D
Exercised, kept
10,000
$0.47
$4.70K
Amir Nashat
25 Jan 2019
Director
Buy indirect
1,125,756
$1.50
$1.69M
Amir Nashat
25 Jan 2019
Director
Buy indirect
11,258
$1.50
$16.89K
Amir Nashat
25 Jan 2019
Director
Buy indirect
7,711
$1.50
$11.57K
Amir Nashat
25 Jan 2019
Director
Buy indirect
21,941
$1.50
$32.91K
Timothy A Springer
25 Jan 2019
Director
Buy indirect
66,666
$1.50
$100.00K
Timothy A Springer
25 Jan 2019
Director
Buy
4,000,000
$1.50
$6.00M
Omid Farokhzad
25 Jan 2019
Director
Buy indirect
83,333
$1.50
$125.00K
Takashi Kei Kishimoto
7 Jan 2019
Chief Scientific Officer
Exercised, kept
36,114
$2.77
$100.04K
Earl Sands
17 Nov 2017
Chief Medical Officer
Buy
7,500
$10.26
$76.97K
David Abraham
14 Nov 2017
GC, CCO & Corporate Secretary
Buy
5,405
$9.25
$50.00K
Timothy A Springer
14 Nov 2017
Director
Buy
57,598
$9.27
$534.09K
Werner Cautreels
13 Nov 2017
President and CEO
Buy
20,000
$9.31
$186.25K
Timothy C Barabe
10 Nov 2017
Director
Buy
2,500
$9.00
$22.50K
Timothy A Springer
10 Nov 2017
Director
Buy
4,752
$9.03
$42.91K
Timothy A Springer
10 Nov 2017
Director
Buy
21,586
$9.04
$195.19K
Timothy A Springer
10 Nov 2017
Director
Buy indirect
4,752
$9.03
$42.91K
Timothy C Barabe
9 Nov 2017
Director
Buy
2,500
$9.73
$24.34K
Timothy A Springer
9 Nov 2017
Director
Buy indirect
100
$9.78
$978.00
Timothy A Springer
9 Nov 2017
Director
Buy indirect
4,900
$9.33
$45.70K
Timothy A Springer
9 Nov 2017
Director
Buy
900
$9.74
$8.77K
Timothy A Springer
9 Nov 2017
Director
Buy
21,100
$9.33
$196.89K
Amir Nashat
26 Sep 2017
Director
Sell indirect
67,764
$18.91
$1.28M
Amir Nashat
26 Sep 2017
Director
Sell indirect
677
$18.91
$12.80K
Amir Nashat
26 Sep 2017
Director
Sell indirect
464
$18.91
$8.77K
Amir Nashat
26 Sep 2017
Director
Sell indirect
1,321
$18.91
$24.98K
Amir Nashat
25 Sep 2017
Director
Sell indirect
35,872
$18.99
$681.14K
Amir Nashat
25 Sep 2017
Director
Sell indirect
359
$18.99
$6.82K
Amir Nashat
25 Sep 2017
Director
Sell indirect
245
$18.99
$4.65K
Amir Nashat
25 Sep 2017
Director
Sell indirect
699
$18.99
$13.27K
Amir Nashat
22 Sep 2017
Director
Sell indirect
40,562
$19.26
$781.39K
Amir Nashat
22 Sep 2017
Director
Sell indirect
406
$19.26
$7.82K
Amir Nashat
22 Sep 2017
Director
Sell indirect
278
$19.26
$5.36K
Amir Nashat
22 Sep 2017
Director
Sell indirect
790
$19.26
$15.22K
Amir Nashat
21 Sep 2017
Director
Sell indirect
100,911
$19.86
$2.00M
Amir Nashat
21 Sep 2017
Director
Sell indirect
1,009
$19.86
$20.04K
Amir Nashat
21 Sep 2017
Director
Sell indirect
690
$19.86
$13.70K
Amir Nashat
21 Sep 2017
Director
Sell indirect
1,967
$19.86
$39.06K
Amir Nashat
20 Sep 2017
Director
Sell indirect
41,116
$20.03
$823.47K
Amir Nashat
20 Sep 2017
Director
Sell indirect
411
$20.03
$8.23K
Amir Nashat
20 Sep 2017
Director
Sell indirect
282
$20.03
$5.65K
Amir Nashat
20 Sep 2017
Director
Sell indirect
801
$20.03
$16.04K
David Siewers
20 Sep 2017
CFO and Treasurer
Sold after exercise
14,230
$20.00
$284.60K
David Siewers
20 Sep 2017
CFO and Treasurer
Sold after exercise
2,194
$20.00
$43.88K
Lloyd P. Johnston
3 Jul 2017
COO and SVP, R*D
Sold after exercise
5,859
$19.09
$111.83K
Lloyd P. Johnston
3 Jul 2017
COO and SVP, R*D
Sold after exercise
100
$19.74
$1.97K
David Siewers
30 Jun 2017
Chief Financial Officer
Sold after exercise
7,420
$20.00
$148.41K
David Siewers
29 Jun 2017
Chief Financial Officer
Sold after exercise
36
$20.00
$720.00
David Siewers
29 Jun 2017
Chief Financial Officer
Sold after exercise
9,616
$20.00
$192.32K
Peter Keller
27 Jun 2017
Chief Business Officer
Sold after exercise
4,595
$19.30
$88.68K
Timothy A Springer
27 Jun 2017
Director
Buy
338,791
$17.71
$6.00M
David Siewers
26 Jun 2017
Chief Financial Officer
Sell
6,886
$20.00
$137.72K
Lloyd P. Johnston
15 Jun 2017
COO and SVP, R*D
Sold after exercise
20,512
$17.00
$348.64K
Timothy A Springer
1 Jun 2017
Director
Buy
518
$13.75
$7.12K
Timothy A Springer
18 May 2017
Director
Buy
4,860
$14.00
$68.04K
Timothy A Springer
17 May 2017
Director
Buy
11,244
$14.01
$157.48K
Edwin Kania
16 May 2017
Director
Sell indirect
266,795
$14.00
$3.74M
Lloyd P. Johnston
17 Apr 2017
COO and SVP, R&D
Sold after exercise
13,205
$13.95
$184.21K
Timothy C Barabe
27 Mar 2017
Director
Exercised, kept
2,492
$11.00
$27.41K
Omid Farokhzad
23 Mar 2017
Director
Exercised, kept
8,019
$7.02
$56.29K
Omid Farokhzad
23 Mar 2017
Director
Exercised, kept
51,981
$3.44
$178.81K
Lloyd P. Johnston
23 Jan 2017
COO and SVP, R&D
Sold after exercise
3,890
$14.17
$55.12K
Lloyd P. Johnston
23 Jan 2017
COO and SVP, R&D
Sold after exercise
11,110
$13.95
$154.98K
Takashi Kei Kishimoto
28 Dec 2016
Chief Scientific Officer
Sold after exercise
10,000
$17.55
$175.50K
David Abraham
21 Dec 2016
CCO, Gen.Counsel, Corp.Sec.
Sold after exercise
14,844
$18.00
$267.19K
Peter Keller
19 Dec 2016
Chief Business Officer
Sell
4,723
$18.58
$87.75K

What was left out

Form 4 filings counted 335
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 31
Sales at will 82
Transactions with no price 1
Shares from compensation/vesting 59,403,783
Sales filed before the plan box existed 65
History held since 23 Jun 2016